Literature DB >> 8789920

Validity of self-administered symptom scales in clients with schizophrenia and schizoaffective disorders.

E K Hamera1, J K Schneider, M Potocky, M A Casebeer.   

Abstract

Few studies have used self-administered symptom scales as outcome measures with individuals who have schizophrenia. However, with the increase in community-based treatment for the serious and persistently mentally ill and the emphasis on client empowerment, their ability to monitor and report symptoms needs to be assessed. Two forms of self-administered items, symptom distress statements and symptom intensity statements, were formed from 10 BPRS symptoms and administered to 29 individuals with schizophrenia. Both forms of self-administered items were highly correlated with BPRS items, supporting concurrent validity. Self-administered responses for positive symptoms of schizophrenia and nonpsychotic symptoms may be more valid than self-administered responses for negative or deficit symptoms.

Entities:  

Mesh:

Year:  1996        PMID: 8789920     DOI: 10.1016/0920-9964(95)00100-x

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  12 in total

1.  Symptom severity and personal functioning among patients with schizophrenia discharged from long-term hospital care into the community.

Authors:  T Trauer
Journal:  Community Ment Health J       Date:  2001-04

2.  Self-Evaluation of Negative Symptoms: A Novel Tool to Assess Negative Symptoms.

Authors:  Sonia Dollfus; Cyril Mach; Rémy Morello
Journal:  Schizophr Bull       Date:  2015-11-12       Impact factor: 9.306

3.  Comparison of self-report and clinician-rated schizotypal traits in schizotypal personality disorder and community controls.

Authors:  Chi C Chan; Andrea Bulbena-Cabre; Sarah Rutter; Caridad Benavides; Margaret M McClure; William Calabrese; Daniel R Rosell; Harold W Koenigsberg; Marianne Goodman; Antonia S New; Erin A Hazlett; M Mercedes Perez-Rodriguez
Journal:  Schizophr Res       Date:  2019-01-08       Impact factor: 4.939

4.  The incremental value of self-reported mental health measures in predicting functional outcomes of veterans.

Authors:  Susan V Eisen; Kathryn A Bottonari; Mark E Glickman; Avron Spiro; Mark R Schultz; Lawrence Herz; Robert Rosenheck; Ethan S Rofman
Journal:  J Behav Health Serv Res       Date:  2011-04       Impact factor: 1.505

Review 5.  A systematic search and critical review of studies evaluating psychometric properties of patient-reported outcome measures for schizophrenia.

Authors:  Benjamin Buck; Emily C Gagen; Tate F Halverson; Arundati Nagendra; Kelsey A Ludwig; John C Fortney
Journal:  J Psychiatr Res       Date:  2021-12-27       Impact factor: 4.791

6.  Dimensional symptom severity and global cognitive function predict subjective quality of life in patients with schizophrenia and healthy adults.

Authors:  Pamela DeRosse; George C Nitzburg; Melanie Blair; Anil K Malhotra
Journal:  Schizophr Res       Date:  2017-10-19       Impact factor: 4.939

7.  Trajectory and early predictors of apathy development in first-episode psychosis and healthy controls: a 10-year follow-up study.

Authors:  Siv Hege Lyngstad; Erlend Strand Gardsjord; Magnus Johan Engen; Beathe Haatveit; Henrik Myhre Ihler; Kirsten Wedervang-Resell; Carmen Simonsen; Ingrid Melle; Ann Færden
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2020-03-04       Impact factor: 5.270

8.  The feasibility and validity of ambulatory self-report of psychotic symptoms using a smartphone software application.

Authors:  Jasper E Palmier-Claus; John Ainsworth; Matthew Machin; Cristine Barrowclough; Graham Dunn; Emma Barkus; Anne Rogers; Til Wykes; Shitij Kapur; Iain Buchan; Emma Salter; Shôn W Lewis
Journal:  BMC Psychiatry       Date:  2012-10-17       Impact factor: 3.630

9.  Can we trust the internet to measure psychotic symptoms?

Authors:  Steffen Moritz; Niels Van Quaquebeke; Tania M Lincoln; Ulf Köther; Christina Andreou
Journal:  Schizophr Res Treatment       Date:  2013-07-10

10.  Ginkgo biloba induced mood dysregulation: a case report.

Authors:  Seung Sun Rho; Young Sup Woo; Won-Myong Bahk
Journal:  BMC Complement Altern Med       Date:  2018-01-15       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.